Avtor/Urednik		Goričar, Katja; Holcar, Marija; Mavec, Nina; Kovač, Viljem; Lenassi, Metka; Dolžan, Vita
Naslov		Extracellular vesicle enriched miR-625-3p is associated with survival of malignant mesothelioma patients
Tip		članek
Vol. in št.		Letnik 11, št. 10
Leto izdaje		2021
Obseg		str. 1-18
ISSN		2075-4426 - Journal of personalized medicine
Jezik		eng
Abstrakt		Malignant mesothelioma (MM) is characterized by poor prognosis and short survival. Extracellular vesicles (EVs) are membrane-bound particles released from cells into various body fluids, and their molecular composition reflects the characteristics of the origin cell. Blood EVs or their miRNA cargo might serve as new minimally invasive biomarkers that would enable earlier detection of MM or treatment outcome prediction. Our aim was to evaluate miRNAs enriched in serum EVs as potential prognostic biomarkers in MM patients in a pilot longitudinal study. EVs were isolated from serum samples obtained before and after treatment using ultracentrifugation on 20% sucrose cushion. Serum EV-enriched miR-103-3p, miR-126-3p and miR-625-3p were quantified using qPCR. After treatment, expression of miR-625-3p and miR-126-3p significantly increased in MM patients with poor treatment outcome (p = 0.012 and p = 0.036, respectively). A relative increase in miR-625-3p expression after treatment for more than 3.2% was associated with shorter progression-free survival (7.5 vs. 19.4 months, HR = 3.92, 95% CI = 1.20-12.80, p = 0.024) and overall survival (12.5 vs. 49.1 months, HR = 5.45, 95% CI = 1.06-28.11, p = 0.043) of MM patients. Bioinformatic analysis showed enrichment of 33 miR-625-3p targets in eight biological pathways. Serum EV-enriched miR-625-3p could therefore serve as a prognostic biomarker in MM and could contribute to a more personalized treatment.
Proste vsebinske oznake		mezoteliom zunajcelični vezikli miR-625 mesothelioma extracellular vesicles miR-625